UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057333
Receipt number R000065532
Scientific Title Development of Mood Variation Biomarkers and Machine Learning Models Utilizing Intracranial EEG in Resting and Task States
Date of disclosure of the study information 2025/04/01
Last modified on 2025/03/18 18:32:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Intracranial EEG Mood State Decoding Study

Acronym

Intracranial EEG-based Mood Decoding

Scientific Title

Development of Mood Variation Biomarkers and Machine Learning Models Utilizing Intracranial EEG in Resting and Task States

Scientific Title:Acronym

SEEG-based Mood Decoding (SEEG-MD)

Region

Japan


Condition

Condition

epilepsy

Classification by specialty

Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We collect intracranial EEG data from epilepsy patients during rest and while presenting emotionally evocative images, using machine learning to identify neural activity patterns associated with mood fluctuations. Specifically, by comparing deep learning models with traditional machine learning models, we aim to explore the feasibility of achieving more accurate and personalized mood fluctuation biomarkers.

Basic objectives2

Others

Basic objectives -Others

The study aims to collect intracranial EEG data from epilepsy patients during both resting states and while viewing emotionally evocative images. The goal is to analyze these signals using machine learning to identify neural activity patterns associated with mood fluctuations. To achieve this, deep learning models will be implemented and compared with traditional machine learning approaches to assess their effectiveness. By evaluating these models, the study seeks to determine the feasibility of developing highly accurate and personalized biomarkers for mood fluctuations. Additionally, the potential clinical applications of these biomarkers for personalized treatment and mood regulation in epilepsy patients will be explored.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The accuracy of machine learning algorithms for predicting patients' mood state

Key secondary outcomes

1.Identification of the most contributing machine learning algorithms, brain regions, frequency bands, and biomarkers for predicting mood fluctuations
2.Verification of intersubject differences in key evaluation metrics


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Record neural activity while presenting emotion-evoking images. The procedure is as follows:
- Each participant is shown 25 images from each of the three categories positive negative and neutral selected from the OASIS dataset forming one session of 25 x 3 images
- Each image is presented for 5 seconds After the presentation of each image a fixation point such as a small dot or cross is displayed at the center of the screen for 400 to 600 milliseconds before the next image appears

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients who are scheduled for or have undergone intracranial electrode implantation to identify the distribution of epileptic foci for surgical treatment of refractory epilepsy and have consented to participate in this study.

Key exclusion criteria

Patients meeting any of the following criteria:
- Severe intellectual disability making task execution difficult
- Expected difficulty in task execution or study participation due to complications or physical decline associated with electrode implantation
- Deemed unsuitable as study subjects by the principal investigator

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Morishita

Organization

Fukuoka university

Division name

Department of Neurosurgery, Faculty of Medicine

Zip code

814-0180

Address

7-45-1 Nanakuma, Jonan-ku, Fukuoka City

TEL

092-801-1011

Email

tmorishita@fukuoka-u.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Morishita

Organization

Fukuoka university

Division name

Department of Neurosurgery, Faculty of Medicine

Zip code

814-0180

Address

7-45-1 Nanakuma, Jonan-ku, Fukuoka City

TEL

092-801-1011

Homepage URL


Email

tmorishita@fukuoka-u.ac.jp


Sponsor or person

Institute

Fukuoka University

Institute

Department

Personal name



Funding Source

Organization

Neuroad, Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukuoka university

Address

7-45-1 Nanakuma, Jonan-ku, Fukuoka City

Tel

092-801-1011

Email

tmorishita@fukuoka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 03 Month 18 Day

Date of IRB

2025 Year 03 Month 10 Day

Anticipated trial start date

2025 Year 03 Month 18 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 03 Month 19 Day

Last modified on

2025 Year 03 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065532